We are live on ! Find out more
ENTXW

Entera Bio Ltd. Warrant
ENTXW

Delisted

ENTXW was delisted on the 27th of June, 2023.

Back to rankings

1 hedge funds and large institutions have $81 invested in Entera Bio Ltd. Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more capital invested

Capital invested by funds: $37 → $81 (+$44)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$80

Top Sellers

No sellers this quarter

ENTXW Hedge Fund Activity: Q1 2023 in Review

1 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q1 2023, worth a combined $81 — up 119% from $37 a quarter earlier.

Fund positioning in ENTXW was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $80.

  • 1 institutional investor held Entera Bio Ltd. Warrant (ENTXW) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $81 of Entera Bio Ltd. Warrant stock for Q1 2023, up 119% quarter-over-quarter.
  • 0 funds opened new Entera Bio Ltd. Warrant positions in Q1 2023 and 0 closed out.
  • The largest Entera Bio Ltd. Warrant buyer in Q1 2023 was UBS Group, an estimated $80 added.

Based on aggregated 13F filings for Q1 2023.